creatine and riluzole
creatine has been researched along with riluzole in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arnold, DL; Cashman, NR; Kalra, S | 1 |
| Pascuzzi, RM | 1 |
| Carter, GT; Krivickas, LS; Miller, RG; Weiss, MD; Weydt, P | 1 |
| da Silva, S; Jiang, F; Snow, RJ; Tarnopolsky, MA; Turnbull, J | 1 |
| Bates, GP; Hockly, E | 1 |
| LeWitt, PA | 1 |
| Brescia Morra, V; Brunetti, A; Carotenuto, B; De Michele, G; Filla, A; Marsili, A; Palma, V; Perrotta, G; Piro, R; Quarantelli, M; Rinaldi, C; Saccà, F; Salvatore, M; Tucci, T | 1 |
Reviews
5 review(s) available for creatine and riluzole
| Article | Year |
|---|---|
Biological markers in the diagnosis and treatment of ALS.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Creatine; Disease Progression; Electromyography; Humans; Magnetic Resonance Imaging; Monitoring, Physiologic; Neuroprotective Agents; Riluzole; Tomography, Emission-Computed | 1999 |
ALS, motor neuron disease, and related disorders: a personal approach to diagnosis and management.
Topics: Adolescent; Adult; Animals; Case Management; Combined Modality Therapy; Creatine; Diagnosis, Differential; Diagnostic Tests, Routine; Disease Models, Animal; Enteral Nutrition; Female; Humans; Male; Mice; Middle Aged; Motor Neuron Disease; Muscular Atrophy, Spinal; Neurologic Examination; Physical Therapy Modalities; Quality of Life; Respiration, Artificial; Riluzole; Tracheostomy | 2002 |
Drug therapy for amyotrophic lateral sclerosis: Where are we now?
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Clinical Trials as Topic; Creatine; Cyclooxygenase Inhibitors; Humans; Neuroprotective Agents; Riluzole; Treatment Outcome | 2003 |
Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
Topics: Acetamides; Animals; Antioxidants; Creatine; Disease Models, Animal; Evaluation Studies as Topic; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Peptides; Point Mutation; Riluzole; Thioctic Acid; Trinucleotide Repeats; Ubiquinone | 2003 |
Clinical trials of neuroprotection for Parkinson's disease.
Topics: Antiparkinson Agents; Clinical Trials as Topic; Creatine; Dopamine Agonists; Double-Blind Method; Humans; Indans; Minocycline; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Nerve Tissue Proteins; Neuroprotective Agents; Oxepins; Parkinson Disease; Picolinic Acids; Randomized Controlled Trials as Topic; Riluzole; Selegiline; Ubiquinone | 2004 |
Trials
1 trial(s) available for creatine and riluzole
| Article | Year |
|---|---|
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Arginine; Choline; Creatine; Double-Blind Method; Endpoint Determination; Female; Hormones; Human Growth Hormone; Humans; Image Processing, Computer-Assisted; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Neuroimaging; Neuroprotective Agents; Recombinant Proteins; Riluzole | 2012 |
Other Studies
2 other study(ies) available for creatine and riluzole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice.
Topics: Age of Onset; Amyotrophic Lateral Sclerosis; Animals; Anterior Horn Cells; Cell Death; Cerebral Cortex; Creatine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Male; Mice; Mice, Transgenic; Muscle, Skeletal; Neuroprotective Agents; Riluzole; Superoxide Dismutase; Treatment Outcome | 2003 |